Pulsatile transdermally administered antigens and adjuvants

Details for Australian Patent Application No. 2004228038 (hide)

Owner Advancis Pharmaceutical Corporation

Inventors Rowlings, Colin E.; Rudnic, Edward M.; Burnside, Beth; Guttendorf, Robert

Agent Spruson & Ferguson

Pub. Number AU-A-2004228038

PCT Pub. Number WO2004/089299

Priority 60/459,763 02.04.03 US

Filing date 2 April 2004

Wipo publication date 21 October 2004

International Classifications

A61K 039/00 Medicinal preparations containing antigens or antibodies

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/089299 Priority application(s): WO2004/089299

13 December 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004228041-Topical anthelmintic veterinary formulations

2004228037-Injection port valve